vs
Side-by-side financial comparison of ZW Data Action Technologies Inc. (CNET) and Context Therapeutics Inc. (CNTX). Click either name above to swap in a different company.
ZW Data Action Technologies Inc. is the larger business by last-quarter revenue ($1.7M vs $1.2M, roughly 1.4× Context Therapeutics Inc.). ZW Data Action Technologies Inc. runs the higher net margin — -6.3% vs -1403.9%, a 1397.6% gap on every dollar of revenue. On growth, Context Therapeutics Inc. posted the faster year-over-year revenue change (328.2% vs -47.0%). Over the past eight quarters, Context Therapeutics Inc.'s revenue compounded faster (154.3% CAGR vs -56.8%).
ZW Data Action Technologies Inc., trading under the symbol CNET, is a China-based technology enterprise focused on delivering integrated digital marketing solutions, big data analysis services, and intelligent operation tools for enterprise clients across sectors including e-commerce, consumer goods, and internet services. Its offerings help clients optimize user acquisition efficiency, boost operational performance, and advance digital transformation, primarily serving the Chinese domestic market and select Asia-Pacific clients.
Context Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing innovative targeted therapies for hormone-driven cancers. Its core pipeline includes candidates for breast, ovarian and other gynecologic malignancies, primarily serving oncology patient populations across North America and Europe.
CNET vs CNTX — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2024
| Metric | | |
|---|---|---|
| Revenue | $1.7M | $1.2M |
| Net Profit | $-108.0K | $-17.5M |
| Gross Margin | 5.7% | — |
| Operating Margin | -8.9% | -1503.7% |
| Net Margin | -6.3% | -1403.9% |
| Revenue YoY | -47.0% | 328.2% |
| Net Profit YoY | 94.4% | -197.2% |
| EPS (diluted) | — | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $1.7M | — | ||
| Q1 25 | $1.7M | — | ||
| Q4 24 | $2.2M | — | ||
| Q3 24 | $3.2M | $1.2M | ||
| Q2 24 | $6.4M | $840.1K | ||
| Q1 24 | $3.5M | — | ||
| Q4 23 | $5.3M | $224.7K | ||
| Q3 23 | $9.2M | $290.4K |
| Q3 25 | $-108.0K | — | ||
| Q1 25 | $-531.0K | — | ||
| Q4 24 | $-781.0K | — | ||
| Q3 24 | $-1.9M | $-17.5M | ||
| Q2 24 | $-216.0K | $-2.3M | ||
| Q1 24 | $-850.0K | — | ||
| Q4 23 | $-1.9M | $-6.8M | ||
| Q3 23 | $-1.5M | $-5.9M |
| Q3 25 | 5.7% | — | ||
| Q1 25 | 9.7% | — | ||
| Q4 24 | -0.4% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 2.0% | — | ||
| Q4 23 | -0.1% | — | ||
| Q3 23 | -0.0% | — |
| Q3 25 | -8.9% | — | ||
| Q1 25 | -35.0% | — | ||
| Q4 24 | -24.1% | — | ||
| Q3 24 | -61.5% | -1503.7% | ||
| Q2 24 | -4.7% | -367.6% | ||
| Q1 24 | -26.1% | — | ||
| Q4 23 | -33.4% | -3085.3% | ||
| Q3 23 | -17.5% | -2128.0% |
| Q3 25 | -6.3% | — | ||
| Q1 25 | -32.1% | — | ||
| Q4 24 | -34.7% | — | ||
| Q3 24 | -59.1% | -1403.9% | ||
| Q2 24 | -3.4% | -268.3% | ||
| Q1 24 | -24.1% | — | ||
| Q4 23 | -36.2% | -3012.6% | ||
| Q3 23 | -16.6% | -2022.7% |
| Q3 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.22 | ||
| Q2 24 | — | $-0.04 | ||
| Q1 24 | — | — | ||
| Q4 23 | — | $-0.42 | ||
| Q3 23 | — | $-0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8M | $84.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.3M | $83.9M |
| Total Assets | $9.7M | $86.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $1.8M | — | ||
| Q1 25 | $807.0K | — | ||
| Q4 24 | $812.0K | — | ||
| Q3 24 | $1.1M | $84.8M | ||
| Q2 24 | $510.0K | $101.5M | ||
| Q1 24 | $467.0K | — | ||
| Q4 23 | $817.0K | $14.4M | ||
| Q3 23 | $1.3M | $21.7M |
| Q3 25 | $3.3M | — | ||
| Q1 25 | $3.1M | — | ||
| Q4 24 | $3.7M | — | ||
| Q3 24 | $4.8M | $83.9M | ||
| Q2 24 | $5.2M | $101.1M | ||
| Q1 24 | $5.4M | — | ||
| Q4 23 | $6.3M | $11.9M | ||
| Q3 23 | $8.2M | $18.4M |
| Q3 25 | $9.7M | — | ||
| Q1 25 | $9.5M | — | ||
| Q4 24 | $9.7M | — | ||
| Q3 24 | $11.0M | $86.3M | ||
| Q2 24 | $10.8M | $102.7M | ||
| Q1 24 | $11.4M | — | ||
| Q4 23 | $11.2M | $16.1M | ||
| Q3 23 | $14.8M | $23.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-482.0K | $-1.9M |
| Free Cash FlowOCF − Capex | — | $-1.9M |
| FCF MarginFCF / Revenue | — | -156.0% |
| Capex IntensityCapex / Revenue | 0.0% | 0.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-482.0K | — | ||
| Q1 25 | $-984.0K | — | ||
| Q4 24 | $-830.0K | — | ||
| Q3 24 | $-198.0K | $-1.9M | ||
| Q2 24 | $-677.0K | $-3.4M | ||
| Q1 24 | $-353.0K | — | ||
| Q4 23 | $-476.0K | $-7.2M | ||
| Q3 23 | $-674.0K | $-3.5M |
| Q3 25 | — | — | ||
| Q1 25 | $-1.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-1.9M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | $-726.0K | — |
| Q3 25 | — | — | ||
| Q1 25 | -61.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -156.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | -7.9% | — |
| Q3 25 | 0.0% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | 0.6% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 0.0% | ||
| Q3 23 | 0.6% | 0.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CNET
| Online Advertising Placement | $1.6M | 95% |
| Other | $83.0K | 5% |
CNTX
Segment breakdown not available.
